PROCEPT BIOROBOTICS CORPORATION - COMMON STOCK

PROCEPT BioRobotics Corp. Announces Investor Event at 2023 AUA Annual Meeting in Chicago

30 Mar 2023 16:05:01 By Nasdaq GlobeNewswire

Aquablation Therapy is the first surgical robotics system to receive a MedTech Innovation Briefing (MIB) from the National Institute for Health Care Excellence

07 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at the Virtual Key Bank Life Sciences & MedTech Investor Forum

02 Mar 2023 16:05:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results

28 Feb 2023 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at the 43rd Annual Cowen Health Care Conference in Boston

13 Feb 2023 16:02:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue  

09 Jan 2023 08:00:01 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference

14 Dec 2022 16:05:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

03 Nov 2022 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Third Quarter 2022 Financial Results on November 3, 2022

12 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces $52 Million Debt Refinancing

10 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Providence Advances Surgical Robotics Program with Multi-System, National Contract for PROCEPT BioRobotics AquaBeam Systems

19 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at 2022 Wells Fargo Healthcare Conference

22 Aug 2022 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

04 Aug 2022 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Second Quarter 2022 Financial Results on August 4, 2022

14 Jul 2022 16:02:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Additional Positive Coverage Policies Regarding Aquablation Therapy for Men with Enlarged Prostates

09 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

05 May 2022 16:02:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Aetna and Independence Blue Cross Blue Shield Positive Coverage Decisions Regarding Aquablation Therapy for Men with Enlarged Prostates

28 Apr 2022 08:00:03 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare Conference on May 11, 2022

12 Apr 2022 16:02:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. Announces Investor Event at 2022 AUA Annual Meeting in New Orleans

11 Apr 2022 08:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2021 Financial Results

08 Mar 2022 07:00:00 By Nasdaq GlobeNewswire